NIH-funded research Career grant

Improving anal cancer screening for people with HIV using genetic testing

Official title: Optimization of anal cancer screening for people with HIV using genomic methods

Funded at Icahn School of Medicine at Mount Sinai · NIH-10785779 · Data updated 2026-11-12

This study is looking to improve how we check for anal cancer in people living with HIV by testing a new, gentler method that uses a special brush to collect samples, and we want to see if it works better than the usual tests.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$187,148
NIH project number1K08CA285939-01
Project IDNIH-10785779 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are at high risk for anal cancer.

Less likely to help

Patients who do not have HIV or those who are not at risk for anal cancer may not benefit from this research.

What this research studies

This research focuses on enhancing the screening process for anal cancer in individuals living with HIV by utilizing genomic methods. The study aims to compare a new genomic test, which uses a cytobrush for sample collection, against standard screening techniques that often yield inaccurate results. By enrolling a cohort of 250 participants, the research will gather data to identify genetic markers associated with precancerous anal lesions, potentially leading to more accurate and less invasive screening methods. The goal is to improve early detection and treatment of anal cancer, thereby reducing morbidity and mortality in this high-risk population.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and less invasive screening methods for anal cancer, ultimately improving patient outcomes.

How similar studies have gone: Previous research has shown promise in using genomic methods for cancer screening, indicating potential success for this novel approach.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Silvera, Richard — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Silvera, Richard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.